Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Gynecologic 1

Conditions

Prostatic Neoplasms 2Progesterone Resistance 1Polycystic Ovary Syndrome 1Obesity 1Endometrial Neoplasms 1Endometrial Hyperplasia 1

Interventions

Tirzepatide 9Exercise 5Counseling 4semaglutide 3Resistance Training 3Methods 3Tablets 2Surveys and Questionnaires 2Standard of Care 2Specimen Handling 2Progestins 2Nutrition Assessment 2Metformin 2Megestrol Acetate 2Diet Therapy 2mirabegron 1bupropion hydrochloride, naltrexone hydrochoride drug combination 1atezolizumab 1Weights and Measures 1Walk Test 1Vitamin D 1Urine Specimen Collection 1Trehalase 1Topiramate 1Therapeutics 1TIC10 compound 1Sugars 1Stents 1Spermine Synthase 1Sampling Studies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Obesity × LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- × 1 year × Clear all
NCT06379113 2025-08-11

GnRHa + Letrozole in Obese Progestin-insensitive Endometrial Cancer Patients

Fudan University

Phase 2/3 Recruiting
29 enrolled
GynecologicOther

Progesterone Resistance, Endometrial Hyperplasia, Obesity, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡